Argentex outperforms profit expectations, advances global expansion plans

08:54, 2nd April 2025
Paul Hill
Paul Hill
PMH Capital
TwitterFacebookLinkedIn

As everyone knows, smallcap investing is definitely not for widows and orphans. However, in order to improve the odds, it is crucial to have a disciplined and structured approach when stock picking. For me, this involves assessing four key factors: Company, Industry, Price vs Value, and Management.

Here, B2B international payments and forex services firm  ()  ticks all the boxes, especially the 4th where I have always rated CEO Jim Ormonde as top notch.

That said, 12 months ago I was highly sceptical of Board's decision to build its own in-house straight-through processing forex platform (AGP) rather than simply buying an off-the-shelf system from a 3rd party.

Fortunately, it appears my concerns were unfounded, as the  engine is beginning to fire on most of its cylinders - albeit vs conservative expectations.

In fact, today after posting better-than-expected FY'24 results, the Board has upgraded guidance, with house broker Singer Capital Markets hiking their adjusted FY25 EBITDA forecast from £1.7m to £4.5m on sales up 5% to £52.8m vs £50.3m LY.

In terms of the balance sheet too, there was net cash of £18.4m as at Dec'24, equivalent to a 'ballpark' headroom of £5m (my guess) that is freely available to  after deducting regulatory requirements.

Sure, going forward, there will still be a temporary drag on performance due to ongoing investments in overseas expansion, new products, and the forex IT platform (AGP) which is slated to go live in the summer.

Yet equally, if you are a risk tolerant investor like myself with long-term time horizons, then I can see  more than doubling over the next 12-24 months.

My target price is 88p/share vs Singer Capital Markets at 70p.

Follow News & Updates from Argentex Group: 

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist